Form 4: SI-BONE Director Jeffrey Dunn Reports RSU Grant and Tax-Related Stock Sale
Insider Transaction Report
SI-BONE, Inc. Director Jeffrey W. Dunn reported the grant of 8,675 restricted stock units and a subsequent 'sell to cover' transaction of 3,377 common shares for tax obligations, as detailed in a recent SEC Form 4 filing.
Summary
- On June 5, 2025, Jeffrey W. Dunn, a Director of SI-BONE, Inc. (SIBN), was granted 8,675 restricted stock units (RSUs) at a price of $0.00 per unit.
- These RSUs are set to vest 100% upon the earlier of the Company's next annual general meeting of stockholders or one year from the Vesting Commencement Date, contingent on Mr. Dunn's continuous service on the Board of Directors.
- Concurrently, on June 5, 2025, Mr. Dunn sold 3,377 shares of SI-BONE common stock at a weighted average price of $19.0509 per share.
- This sale was explicitly identified as a 'sell to cover' transaction, executed to fulfill tax withholding obligations arising from the vesting of restricted stock units, and was not a discretionary trade.
- Following these transactions, Mr. Dunn's direct beneficial ownership of SI-BONE common stock stands at 17,354 shares, which includes 11,940 shares issuable upon the settlement of other restricted stock units.
- An additional 112,413 shares are held indirectly by The Jeffrey W. Dunn Living Trust dated May 17, 2012.
Sentiment
Score: 5
Explanation: The document reports routine insider transactions (RSU grant and tax-related sale) which are expected and do not inherently indicate positive or negative sentiment regarding the company's performance or outlook. It's a neutral, factual disclosure.
Positives
- The grant of 8,675 restricted stock units (RSUs) to Director Jeffrey W. Dunn indicates continued alignment of management incentives with shareholder interests and ongoing compensation for his service.
- The RSU grant at a $0.00 price is a common form of equity compensation, providing future value to the director as the company's stock price appreciates.
Negatives
- The sale of 3,377 shares, even if for tax purposes, reduces the direct common stock holdings of a director, which could be perceived as a minor reduction in direct insider ownership.
Future Outlook
The 8,675 restricted stock units granted to Director Jeffrey W. Dunn are scheduled to vest 100% upon the earlier of the next annual general meeting of the Company's stockholders or one year from the Vesting Commencement Date, provided his continuous service as a Board member.
Management Comments
- "The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person."
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, common across all publicly traded companies. It reflects standard equity compensation practices for directors, including the grant of restricted stock units and subsequent 'sell to cover' transactions to manage tax liabilities upon vesting. Such filings provide transparency into insider holdings and compensation structures.
Related Party Transactions
- Shares are held indirectly by The Jeffrey W. Dunn Living Trust dated May 17, 2012, which is a related party to the reporting person.
Stakeholder Impact
- Shareholders: The RSU grant aligns the director's interests with shareholders, while the 'sell to cover' transaction is a minor, non-discretionary reduction in direct insider holdings, unlikely to significantly impact shareholder perception.
- Employees: No direct impact mentioned.
Next Steps
- Vesting of the 8,675 restricted stock units will occur upon the earlier of the next annual general meeting of stockholders or one year from the Vesting Commencement Date.
Key Dates
| Date | Description |
|---|---|
| May 17, 2012 | Date of The Jeffrey W. Dunn Living Trust. |
| June 5, 2025 | Transaction date for both the RSU grant and the common stock sale. |
| June 6, 2025 | Signature date of the reporting person's attorney-in-fact. |
Keywords
SI-BONE, SIBN, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Sell to Cover, Beneficial Ownership, Director Stock, Equity Compensation, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.